Mylan Hit With $69.2M In Treble Damages

January 25, 2008

All Content Copyright 2007, Portfolio Media, Inc.

Blue Cross Blue Shield of Massachusetts and three other health insurance firms that opted out of a $35 million class-action settlement against Mylan Laboratories Inc. to pursue their own antitrust allegations have won a whopping $69.2 million award in treble damages.

Back to Top